Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen

Marimastat is a specific inhibitor of matrix metalloproteinases that has been shown to be effective in cancer models. A pilot, escalating-dose study of oral marimastat was performed in patients with recurrent colorectal cancer, in whom evaluation of serological response was made by measurement of ca...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Primrose, J N, Bleiberg, H, Daniel, F, Belle, S Van, Mansi, J L, Seymour, M, Johnson, P W, Neoptolemos, J P, Baillet, M, Barker, K, Berrington, A, Brown, P D, Millar, A W, Lynch, K P
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1999
Teme:
Regular Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362442/
https://ncbi.nlm.nih.gov/pubmed/10027321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690079
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items